Christophe Chaignot1, Alain Weill1, Philippe Ricordeau1, François Alla2. 1. Département Études de Santé Publique, Caisse Nationale de l'Assurance Maladie des Travailleurs Salariés, Paris, France. 2. Direction Générale, Caisse Nationale de l'Assurance Maladie des Travailleurs Salariés, Paris, France.
Abstract
AIM: To quantify and describe the population starting treatment with baclofen for alcohol dependence during the period 2007-2013 in France. METHODS: The French national health insurance (système national d'information inter-régimes de l'Assurance maladie [SNIIRAM]) and French hospital discharge (programme de médicalisation des systèmes d'information [PMSI]) databases were used to identify the population starting treatment with baclofen, determine the algorithm of baclofen use, define patient characteristics and their treatment. RESULTS: About 200,000 subjects initiated baclofen therapy between 2007 and 2013, for alcohol dependence in 52.0% of cases. In 2013, this population was predominantly male (62.3%), with a mean age of 50.1 years, the first prescriber was a general practitioner in 58.9% of cases, they continued their treatment 6 months after their initiation in 48.8% of cases and one half of these subjects consumed at least 57.0 mg of baclofen daily. CONCLUSIONS: The use of baclofen for alcohol dependence increased considerably since 2008, with more than 34,000 new users and more than 9,000 general practitioners as first prescribers in 2013.
AIM: To quantify and describe the population starting treatment with baclofen for alcohol dependence during the period 2007-2013 in France. METHODS: The French national health insurance (système national d'information inter-régimes de l'Assurance maladie [SNIIRAM]) and French hospital discharge (programme de médicalisation des systèmes d'information [PMSI]) databases were used to identify the population starting treatment with baclofen, determine the algorithm of baclofen use, define patient characteristics and their treatment. RESULTS: About 200,000 subjects initiated baclofen therapy between 2007 and 2013, for alcohol dependence in 52.0% of cases. In 2013, this population was predominantly male (62.3%), with a mean age of 50.1 years, the first prescriber was a general practitioner in 58.9% of cases, they continued their treatment 6 months after their initiation in 48.8% of cases and one half of these subjects consumed at least 57.0 mg of baclofen daily. CONCLUSIONS: The use of baclofen for alcohol dependence increased considerably since 2008, with more than 34,000 new users and more than 9,000 general practitioners as first prescribers in 2013.
Authors: Sovandara Heng; Nazila Jamshidi; Andrew Baillie; Eva Louie; Glenys Dore; Nghi Phung; Paul S Haber; Kirsten C Morley Journal: Front Psychiatry Date: 2018-11-19 Impact factor: 4.157
Authors: Kirsten C Morley; Jim Lagopoulos; Warren Logge; Kate Chitty; Andrew Baillie; Paul S Haber Journal: Front Psychiatry Date: 2018-09-04 Impact factor: 4.157